Mizuho Reiterates Outperform Rating on Insmed (INSM), maintains as 'top June 2025 pick'
Tweet Send to a Friend
Mizuho analyst Graig Suvannavejh reiterated an Outperform rating and $110.00 price target on Insmed (NASDAQ: INSM).The analyst commented: "Yesterday, we ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
